Gut Microbiome Dysbiosis and Immunometabolism: New Frontiers for Treatment of Metabolic Diseases
Open accessThe DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.
Abstract
Maintenance of healthy human metabolism depends on a symbiotic consortium among bacteria, archaea, viruses, fungi, and host eukaryotic cells throughout the human gastrointestinal tract. Microbial communities provide the enzymatic machinery and the metabolic pathways that contribute to food digestion, xenobiotic metabolism, and production of a variety of bioactive molecules. These include vitamins, amino acids, short-chain fatty acids (SCFAs), and metabolites, which are essential for the interconnected pathways of glycolysis, the tricarboxylic acid/Krebs cycle, oxidative phosphorylation (OXPHOS), and amino acid and fatty acid metabolism. Recent studies have been elucidating how nutrients that fuel the metabolic processes impact on the ways immune cells, in particular, macrophages, respond to different stimuli under physiological and pathological conditions and become activated and acquire a specialized function. The two major inflammatory phenotypes of macrophages are controlled through differential consumption of glucose, glutamine, and oxygen. M1 phenotype is triggered by polarization signal from bacterial lipopolysaccharide (LPS) and Th1 proinflammatory cytokines such as interferon-γ, TNF-α, and IL-1 β, or both, whereas M2 phenotype is triggered by Th2 cytokines such as interleukin-4 and interleukin-13 as well as anti-inflammatory cytokines, IL-10 and TGF β, or glucocorticoids. Glucose utilization and production of chemical mediators including ATP, reactive oxygen species (ROS), nitric oxide (NO), and NADPH support effector activities of M1 macrophages. Dysbiosis is an imbalance of commensal and pathogenic bacteria and the production of microbial antigens and metabolites. It is now known that the gut microbiota-derived products induce low-grade inflammatory activation of tissue-resident macrophages and contribute to metabolic and degenerative diseases, including diabetes, obesity, metabolic syndrome, and cancer. Here, we update the potential interplay of host gut microbiome dysbiosis and metabolic diseases. We also summarize on advances on fecal therapy, probiotics, prebiotics, symbiotics, and nutrients and small molecule inhibitors of metabolic pathway enzymes as prophylactic and therapeutic agents for metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to regulation of infection and commensal spread, microbiome-immune interactions are implicated in a variety of ‘non-communicable’ gastrointestinal diseases including inflammatory bowel disease (IBD)8 and celiac diseases,9 as well as extra-intestinal disorders ranging from rheumatic arthritis,10 metabolic syndrome,11 neurodegenerative disorder12 to malignancy.13”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [11]
In the citing paper
“Changes in this microbial equilibrium that is, dysbiosis can promote and influence the course of many intestinal and extra-intestinal diseases[14-16].”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“Several important questions on the complex interaction between host and microbes in pathophysiology of obesity remain answered [49, 74, 75].”
BackgroundA human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 2×
“Several important questions on the complex interaction between host and microbes in pathophysiology of obesity remain answered [49, 74, 75].”
BackgroundEnterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 2×
“Unstimulated macrophages displaying M0 phenotype and exhibiting the differentiation surface markers CD68/ CD80//CD206 acquire and display the M1 phenotype (CD68/CD80//CD206) or M2 phenotype (CD68/ CD80/CD206/) after switching their metabolism and function in response to stimuli or polarization signals that initiate a…”
BackgroundThe gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245 · cited 1×
“Initial clues for the role of microorganisms in energy homeostasis and obesity appeared from the studies using germ-free animals [76].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425 · cited 1×
“A collection of 100-400× 10(12) of bacteria inhabits and lives in mutualistic relationships in the human GI tract [3].”
BackgroundMiller, M. B., & Bassler, B. L. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.165 · Cited by 5,105 · cited 1×
“Finally, bacteria can inhibit the growth of their competitors by long distance microbial communication, via release of metabolites and quorum sensing peptides, which are considered a biological strategy for maintenance of density of commensal species, and elimination of pathogenic bacteria [23, 24].”
Background
Cited by
Items 301–397 of 397
Gut microbiota, nutrition, and health
Michael, O. S., Adetunji, J. B., Adeyanju, O. A., Adetunji, C. O., Badmus, O. O., Olaniyi, K. S., & Soladoye, A. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91190-0.00011-4 · Cited by 1
Bircan, H., Demircan, T., Yülek, F., & Yüksel, N. (2024) · International Ophthalmology · doi:10.1007/s10792-024-03386-1 · Cited by 1
“Recent studies have shown the impact of differences in the microbiome and microbiome-related metabolic pathways on the pathogenesis of congenital diseases [4].”
de Proença, L. G. B., & Macedo, A. C. G. (2025) · International Journal of Nutrology · doi:10.54448/ijn25209 · Cited by 1
“These include vitamins, amino acids, short-chain fatty acids, and metabolites, which are essential for the interconnected pathways of glycolysis, the tricarboxylic acid/Krebs cycle, oxidative phosphorylation, and amino acid and fatty acid metabolism [15] .”
Campolina, A. C. G. D. L. B. (2022) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
What is Dysbiosis and, in which Parts of the Organism Exists?
Tiburcio, Á. Z. (2019) · Gastroenterology Medicine & Research · doi:10.31031/gmr.2019.04.000580
“As well as those who refer to the metabolic syndrome [41].”
BackgroundMicrobiota and Network Medicine
Semidotskaya, Z. D., Chernyakova, I. A., Неффа, М. Ю., & Чернякова, А. Е. (2019) · Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · doi:10.15407/internalmed2019.02.005
Gut Microbiota and Extraintestinal Disorders: Are They Interrelated?
Chandra, A., Ray, A. K., Chakraborty, U., & Hati, A. (2021) · Bengal Physician Journal · doi:10.5005/jp-journals-10070-7012
Potential efficacy of gut microbiome dysbiosis on alleviation the progress of osteoarthritis in micePreprint
Guan, Z., Jia, J., Zhang, C., Sun, T., Zhang, W., Leng, H., & Song, C. (2020) · Research Square · doi:10.21203/rs.3.rs-28047/v1
Udenwagu, J., Eyobio, U.-A., Onyechi, S., Diego, V. P., Almeida, M., Howard, T. E., & Blangero, J. (2019) · ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley)
Recent advances in blood and gut microbiota biomarkers for Alzheimer’s disease
Wu, S., Li, H., Tong, L., & Zhou, L. I. U. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0100
Gut Microbiome as Potential Source for Prevention of Metabolic‐Related Diseases
Boonlao, N., Pant, K., & Anal, A. K. (2022) · Wiley eBooks · doi:10.1002/9781119702160.ch17
Chakrabarti, S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738582898.793579467
The Microbiome and Cancer: A Dangerous Liaison
Meisel, A. (2021) · healthbook TIMES Oncology Hematology · doi:10.36000/hbt.oh.2021.08.035
Yadati, T. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20211118ty
Het Warburg-effect bij niet-neoplastische cellen: toekomstmogelijkheden voor het paard?
Kootwijk, F. J. V., & Ducatelle, R. (2022) · Vlaams Diergeneeskundig Tijdschrift · doi:10.21825/vdt.84794
Introduction: From the Gut Microbiome to the Ocular Surface Microbiome—Are They Associated?
Shivaji, S. (2022) · Springer eBooks · doi:10.1007/978-981-19-1754-7_1
Nigella sativa oil of «diana» sort in the therapy of antibiotics simulated dysbiosis
Tolstanova, G. M., Serhiichuk, T., Aleksandrova, I., Korbush, M., & Dovbynchuk, T. (2022) · Journal of Microbiology & Experimentation · doi:10.15406/jmen.2022.10.00373
Gut dysbiosis: A pathway to glucose dysregulation?
Lawal, Y. (2022) · Journal of Current Research in Scientific Medicine · doi:10.4103/jcrsm.jcrsm_48_21
Juárez‐Fernández, M. (2023) · Buleria (Universidad de León) · doi:10.18002/10612/17419
Sorokina, D. M., Shaidullov, I. F., Buchareb, D., Ситдиков, Ф. Г., & Ситдикова, Г. Ф. (2023) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747823060089
Borshchev, Y. Y., Минасян, С. М., Karaseva, A. B., Burovenko, I. Y., Borshchev, V. Y., Borshchev, Y. Y., Burovenko, D. V., Suvorov, A. N., & Galagudza, M. M. (2023) · Medical Immunology (Russia) · doi:10.15789/1563-0625-teo-2611
Cambios en las recomendaciones de cirugía bariátrica metabólica
Martínez, W. A. R., Abreu-Lomba, A., Arias, R., & Vélez, J. P. (2024) · Interdisciplinary Journal of Epidemiology and Public Health · doi:10.18041/2665-427x/ijeph.1.10233
Overview of Research on Immune Factors Associated with Bronchopulmonary Dysplasia
龚, 小. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.143821
Synbiotics as a Nutraceutical Adjuvant: Neuroprotective and Neurorestorative Effects
Nadar, R. M., Liu, K., Pathak, S., DeRuiter, J., Ramapuram, J. B., Lynn, G., Carl, B., Dua, K., Moore, T. M., & Dhanasekaran, M. (2024) · Springer eBooks · doi:10.1007/978-981-99-5575-6_18
SÍNDROME METABÓLICA: EVIDÊNCIAS DA INFLAMAÇÃO E DISBIOSE ENQUANTO DETERMINANTES DO CONSUMO ALIMENTAR
Moreira, A. L. D. S., Cavalcante, M. C. M., da Fonseca, M. D. L. A., de Albuquerque, L. P., & Rodrigues, G. P. (2024) · Editora Omnis Scietia eBooks · doi:10.47094/978-65-6036-382-3/35-46
ROLE OF MICROBIOTA-GUT-BRAIN AXIS IN AUTISM SPECTRUM DISORDER
Santos, J. V. F., & Barbosa, M. H. (2025) · International Seven Journal of Health Research · doi:10.56238/isevjhv4n2-003
Furst, L. E., Hill, H. R., & Lapine, T. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00258-2
Ko, G., Park, M. H., Jo, H., Lee, E., & Kim, C.-S. (2025) · Journal of Applied Biological Chemistry · doi:10.3839/jabc.2025.031
Gut Microbiota Signatures as Predictive Biomarkers for Metabolic and Gastrointestinal Diseases
Barkat, H. A., Masood, B., Saif, A., Jadoon, H., Kiyani, T., & Ullah, S. (2025) · Indus journal of bioscience research. · doi:10.70749/ijbr.v3i10.2536
Unveiling the Synapses: Gut Microbiota and Neurodegenerative Disorders Through the Gut–Brain AxisPreprint
Mohammad, I., Ansari, M. R., Bari, M. N., Khan, M. S., Kamal, M. A., & Poyil, M. M. (2025) · Preprints.org · doi:10.20944/preprints202512.0691.v1
Das Immunsystem – Regelgröße zur Beeinflussung der Zusammensetzung des Mikrobioms?
Bechberger, M. (2024) · heiDOK (Heidelberg University) · doi:10.11588/heidok.00035389
Shigeta, M., Aoi, W., Morita, C., Soga, K., Inoue, R., Fukushima, Y., Kobayashi, Y., & Kuwahata, M. (2024) · Figshare · doi:10.6084/m9.figshare.26602099
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678960
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678951
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678927
Ο ρόλος του μικροβιώματος σε φλεγμονώδεις καταστάσεις
Nousias, A. (2021) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.11017
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678930
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.25195132
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678936
Shigeta, M., Aoi, W., Morita, C., Soga, K., Inoue, R., Fukushima, Y., Kobayashi, Y., & Kuwahata, M. (2024) · Figshare · doi:10.6084/m9.figshare.26602108
Shigeta, M., Aoi, W., Morita, C., Soga, K., Inoue, R., Fukushima, Y., Kobayashi, Y., & Kuwahata, M. (2024) · Figshare · doi:10.6084/m9.figshare.26602096
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678954
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.25194812
Shigeta, M., Aoi, W., Morita, C., Soga, K., Inoue, R., Fukushima, Y., Kobayashi, Y., & Kuwahata, M. (2024) · Figshare · doi:10.6084/m9.figshare.26602090
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678942
Shigeta, M., Aoi, W., Morita, C., Soga, K., Inoue, R., Fukushima, Y., Kobayashi, Y., & Kuwahata, M. (2024) · Figshare · doi:10.6084/m9.figshare.26602102
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678957
Merkmale des Darmmikrobioms bei Diabetes mellitus Typ 1 und Depression (MIDIAD-Studie)
Hirsch, J. R. (2023) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · doi:10.13154/294-9876
Han, S.-K., Kim, J.-K., Park, H.-S., Shin, Y.-J., & Kim, D.-H. (2021) · Figshare · doi:10.6084/m9.figshare.15178938
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678933
Shigeta, M., Aoi, W., Morita, C., Soga, K., Inoue, R., Fukushima, Y., Kobayashi, Y., & Kuwahata, M. (2024) · Figshare · doi:10.6084/m9.figshare.26602105
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678945
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678939
Huang, Y., Huang, X., Wang, Z., He, F., Huang, Z., Chen, C., Tang, B., Qin, M., Wu, Y., 龙陈艳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26678948
Herrera Azcona, A. (2021) · Rovira & Virgili repository
Microbiota as indicator of intestinal health and modulation strategies
Oliver Galindo, L. (2024) · DUGiDocs (Universitat de Girona)
Teixeira, C. S. R. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/4j1f-tm07
MARIANELLI, L. (2025) · Electronic Theses and Dissertations Repository (University of Pisa)
王, 怡. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1592713
Immunometabolic Responses upon Bacterial Infections
Soni, V., & Upadhyay, A. (2026) · Springer eBooks · doi:10.1007/978-3-031-46895-7_8
Freitas, G. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Ajadi, K. A., Ogunleye, O. O., Jibodu, A. O., Abuah, A. O., Diya, O. O., Onochie, B. B., Irivradje, P. O., Daramola, O.-O. O., & Osho, A. (2026) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/7118611
Pro-, Post- and Pre-biotics for Health and Longevity
Bas, M., & Kahrıman, M. (2026) · Healthy ageing and longevity · doi:10.1007/978-3-032-11608-6_3
Yadav, M., Kumar, S., Kumar, S., Singh, M., & Sehrawat, N. (2025) · De Gruyter eBooks · doi:10.1515/9783112205150-001
Abedi, A., Moghaddam, M. M., Kachuei, R., & Fooladi, A. A. I. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01171-5
Metabolic actions of the gut microbiota in obesity: a systematic review
Leite, C. M. O., Richter, P. W., Andrade, C. V., Alvim, F. A. V., Cruz, F. A. S., de Oliveira, G. L., Dias, I. H. R., Lima, L. V., de Brito, V. C. B., & Durante, F. R. (2026) · International Journal of Nutrology · doi:10.54448/ijn26207
Joshi, R., Dwivedi, J., Singh, S., Paliwal, S., Sharma, S., Mishra, A., & Singh, S. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02357-0
Effet des microplastiques sur les jeunes stades de vie des poissons marins
Jacob, H. (2019) · theses.fr (ABES) · doi:10.70675/b6571f3bzd1e3z4c2cz8042z40664ce73aa1
de Oliveira, C. C. F., Nylén, A., Ljung, J., Welin, A., Arvidsson, L., Martí, M., Govindaraj, D., Martín, I. G., Janefjord, C., Tingö, L., et al. (2026) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-026-01036-y
“The composition of the gastrointestinal (GI) microbiota plays a crucial role in metabolism and immunological functions across tissues and organs [7].”
Bhatt, M., & Desai, H. (2026) · Research Journal of Pharmacognosy and Phytochemistry · doi:10.52711/0975-4385.2026.00024
Zhang, Y., Chen, Y., Huang, Z., Zheng, S., Shen, C., Wang, Q., Chen, H., He, S., Yang, Q., Ou, Z., et al. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.72015
“Dysregulated interactions between metabolic tissues and immune cells, exacerbated by gut dysbiosis, further promote systemic inflammation through PRRs recognizing LPS and other pathogen-associated molecules (Belizário et al. 2018).”
Боровська, Є. В. (2023) · INSTITUTIONAL REPOSITORY OF ODESSA NATIONAL UNIVERSITY NAMED I.I. Mechnykova (Odesa I.I.Mechnikov National University)
Youngblood, V., Armstrong, T. D., Nguyen, K. N., Green, A. E., Kelly, M. E., Johnson, B., Stanley, A. H., Gilbreth, P., Cook, M. (., Coxe, T., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10713368/v1
“Modulation of these microbial-derived signaling pathways has been implicated in the development of systemic metabolic dysfunction and may represent a mechanistic link between environmental exposures and adverse metabolic outcomes (21).”
Research Progress on the Relationship Between Radiation Enteritis and Gut Microbiota Dysbiosis
Xu, J., Liu, Y., Xiao, Y., Chen, Y., Meng, E., Jin, M., Wu, M., Zong, Y., & Liu, H. (2026) · Cancer Management and Research · doi:10.2147/cmar.s640003
Metaproteomic portrait of the gut microbiome in children with Down syndromePreprint
Marzano, V., Pirona, I., Rapisarda, F., Marangelo, C., Macari, G., Mortera, S. L., Vernocchi, P., Agolini, E., Dallapiccola, B., Novelli, A., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10623142/v1
Yu, M., Guo, P., Liu, Q., & Zhang, X. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2726635
“In particular, microbial enzymatic activities facilitate the production of vitamins, amino acids, and SCFAs, which collectively contribute to food digestion, xenobiotic metabolism, and host metabolic balance [13].”
Understanding the microbiome: Microbiome and immune system interactions
Goel, K., Chawla, I., Sharma, S., Siddiqui, N. A., & Gupta, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33206-7.00010-8
Prachumchalad, M., Siangsanun, A., Meeprom, C., Kittichontawat, S., Homkhao, J., & Jandee, N. (2025) · Agriculture & Technology RMUTI Journal
Gutiérrez, G., Azpiroz, M. A., Mayol, S., Orguilia, L., Guerrero, M. J., Malpartida, A., & Cerimedo, F. (2023) · Revista Sociedad Argentina de Endocrinología Ginecológica y Reproductiva
Xenosensors in the gut–liver Axis: from microbiome metabolites to toxic response variability
Motafeghi, F. S., Barghi, E. G., Rahmani, P., Gharab, J. G., Ashari, S., & Ghassemi-Barghi, N. (2026) · Toxicology Research · doi:10.1093/toxres/tfag076
Xie, L., Hu, Y., Du, K., 刘克成, Yang, S., Zhou, Y., Zhang, Q., & Lan, C. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1931987
“…studies have shown that gut microbial dysbiosis is associated with a broad spectrum of disorders, including metabolic diseases, neurological disorders, systemic inflammation, and cardiovascular diseases (Belizário et al., 2018; Kim, 2018; Kim et al., 2017; Ullah et al., 2023; Yang and Cong, 2021).”
Therapeutic Role of Centella asiatica (L.) in Gut Dysbiosis Induced by Environmental Toxic Metals
Ekka, R., Naik, K., Chandel, S. S., Sahu, S. K., & Ahirwar, B. (2026) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2026.00689
Central epigenetic mechanisms of overeating and thermal regulation
Meiri, N., & Weller, A. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19043-8.00020-7
Sharma, R., Kumar, G., & Thakur, A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02433-w
Li, M., Kong, X., Meng, F., Liu, Y., Qin, S., Liu, B., & Xue, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1923673
From microbiome to macula: The role of probiotics in retinal neuroprotection
Goyal, S., & Vanita, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45154-6.00014-3
What do we really know about human immunometabolism in inflammatory disease?
Gunawardana, S., Arocha, S. R. R., & Clarke, A. J. (2026) · Clinical & Experimental Immunology · doi:10.1093/cei/uxag075
Zhang, D., Xu, Y., Chen, H., Wang, D., Geng, Z., Chen, Y., Chen, Y., Xiong, D., Yang, R., Liu, X., et al. (2022) · doi:10.3389/fnut.2022.993501.s001
Sun, R., Jin, D., Fei, F., Xu, Z., Cao, B., & Li, J. (2023) · doi:10.3389/fphar.2023.1172963.s004
Supporting information 1 of Host Immunity Influences the Composition of Murine Gut Microbiota
averbeke, V. V., Berkell, M., Mysara, M., Rodriguez-Ruiz, J. P., Xavier, B. B., Winter, F. H. R. D., Jongers, B. ‘., Jairam, R. K., Hotterbeekx, A., Goossens, H., et al. (2022) · doi:10.3389/fimmu.2022.828016.s001
Sun, R., Jin, D., Fei, F., Xu, Z., Cao, B., & Li, J. (2023) · doi:10.3389/fphar.2023.1172963.s007
Park, Y., Zhang, Q., Fernandes, J. M. O., Wiegertjes, G. F., & Kiron, V. (2021) · doi:10.3389/fimmu.2021.798156.s002
Lei, Y., Xu, M., Huang, N., & Yuan, Z. (2023) · doi:10.3389/fcvm.2023.1154888.s010
Galena, A. E., Chai, J., Zhang, J., Bednarzyk, M., Perez, D., Ochrietor, J. D., Jahan-Mihan, A., & Arikawa, A. Y. (2022) · doi:10.1371/journal.pone.0275275.r005
Metadata
- Authors
- Belizário, J. E., Faintuch, J., & Garay-Malpartida, M.
- Affiliations
- Universidade de São Paulo (BR)
- Corresponding author
- Belizário, José E.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2018-12-09
- Volume
- 2018
- Pages
- 1-12
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC6304917
- OpenAlex
- W2904076340
- Cited by
- 341
- References
- 101
- Citations by year
- 2026: 27 · 2025: 34 · 2024: 55 · 2023: 46 · 2022: 64 · 2021: 47 · 2020: 51 · 2019: 17
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2015/18647-6, 2007/04513-1, 312206/2016-0, 308794/2014-1, 2011/188-37)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- gut dysbiosis, immunometabolism, macrophage polarization, M1/M2 macrophages, short-chain fatty acids, microbial metabolites, low-grade inflammation, metabolic disorders, obesity, diabetes mellitus, metabolic syndrome, cancer, fecal microbiota transplantation, probiotics, prebiotics, symbiotics, small molecule inhibitors, host-microbe interactions
- MeSH terms
- Gastrointestinal Microbiome, Animals, Humans, Macrophages, Metabolic Diseases, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.